Phase 1 Oncology Clinical Trial Designs: Adaptive Strategies That Accelerate Milestones and De-Risk Regulatory Approval
Precision for Medicine2025-12-1936 页
Malaysia: The New Destination for Early Phase Trials
IQVIA2025-12-2122 页
Phase 1 Oncology Clinical Trial Designs: Adaptive Strategies That Accelerate Milestones and De-Risk Regulatory Approval
Precision for Medicine2025-12-2136 页
2026年全球干细胞行业发展蓝皮书
弗若斯特沙利文2026-07-31124 页
How NIH-Funded Science Supports US Biopharmaceutical Innovation
Information Technology and Innovation Foundation (ITIF)2025-12-2526 页
2025 中国健康医疗数据要素应用案例集
2026-01-1578 页
A New, AI-Augmented Horizon for Safety and Pharmacovigilance: Expert Predictions for 2026
IQVIA2026-01-1712 页
12月全球新药月报-分析篇
Insight2026-01-1935 页
FDA’s Rare Disease Evidence Principles (RDEP): Use Real-World Evidence in Ultra-Rare Drug Development
IQVIA2026-01-237 页